KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 77 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34 | -100.0% | 18,799 | -16.3% | 0.00% | -66.7% |
| Q3 2022 | $123,000 | -65.4% | 22,469 | -71.5% | 0.01% | -70.0% |
| Q2 2022 | $355,000 | -9.4% | 78,720 | +29.0% | 0.04% | -7.0% |
| Q4 2021 | $392,000 | -38.9% | 61,045 | +0.1% | 0.04% | -40.3% |
| Q1 2021 | $642,000 | +247.0% | 61,002 | +411.1% | 0.07% | +140.0% |
| Q4 2020 | $185,000 | -43.1% | 11,936 | -37.5% | 0.03% | -33.3% |
| Q3 2018 | $325,000 | +261.1% | 19,084 | +88.0% | 0.04% | +87.5% |
| Q1 2016 | $90,000 | – | 10,153 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |